TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/20/23 16:32 | 1/20/23 | CLSD | Clearside Biomedical, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ciulla Thomas | GA | O | Chief Me | S | -20 | 1.47 | 0 | -14 | -4 | 292 | D | ||||||||||||||
1/11/23 16:39 | 1/10/23 | CLSD | Clearside Biomedical, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ciulla Thomas | GA | O | Chief Me | S | -4 | 1.62 | 0 | -2 | -1 | 306 | D | ||||||||||||||
1/20/22 19:06 | 1/19/22 | CLSD | Clearside Biomedical, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ciulla Thomas | GA | O | Chief Me | S.d | -19 | 2.13 | 0 | -9 | -3 | 295 | D | ||||||||||||||
9/23/21 17:17 | 9/21/21 | CLSD | Clearside Biomedical, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ciulla Thomas | GA | O | Chief Me | S | -16 | 6.40 | 0 | -3 | -1 | 256 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |